共 70 条
[1]
MacFarlane JK(1993)Mesorectal excision for rectal cancer Lancet 341 457-460
[2]
Ryall RD(2007)The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma Ann Surg 246 693-701
[3]
Heald RJ(2012)Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial Lancet Oncol 13 616-621
[4]
Peeters KC(2007)Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer Ann Surg 246 754-762
[5]
Marijnen CA(2009)A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence Ann Surg 249 229-235
[6]
Nagtegaal ID(2007)Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study Surgery 141 67-75
[7]
Fujita S(2006)Indication and benefit of pelvic sidewall dissection for rectal cancer Dis Colon Rectum 49 1663-1672
[8]
Akasu T(2006)Chemotherapy with preoperative radiotherapy in rectal cancer N Engl J Med 355 1114-1123
[9]
Mizusawa J(2004)Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 1731-1740
[10]
Kim JC(2009)Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 3109-3116